Developer docs
API playgroundTry for free, no card

Search company profiles

Laverty Pathology

Full company profile

uuid000ffj2

Namestring
Laverty Pathology
Legal namestring
Healius Pathology Pty Ltd
Websiteurl
laverty.com.au
Company typeenum
Private
Founded yearint
1928
Descriptiontext

Laverty Pathology is a major provider of pathology and medical diagnostic services in New South Wales and the Australian Capital Territory, operating as a brand under Healius Pathology Pty Ltd — a wholly-owned subsidiary of Healius Ltd, an ASX top-100 listed healthcare group. The business traces its heritage to 1928, when Dr Eva Shipton established one of Australia's first specialist pathology practices in Sydney; over decades it grew by absorbing successive pathology practices (Maynard, Orban, Lindsell, Hale, Cottom, Woods, Moses, Patwardhan) and was reconstituted in 2008 through the merger of SDS Pathology with Symbion Laverty Pathology. Today Laverty runs more than 550 patient collection centres across NSW and ACT, supports more than 20,000 Australian clinicians annually via its Healius MQLink electronic data interchange (EDI) software, and operates as part of a 2,000+-centre national network through Healius.

The company's core product is medical pathology testing — blood, body fluid, tissue, cytology, infectious disease, genetic/molecular, hormone, and occupational health testing — delivered through NATA-accredited laboratories certified to ISO 15189 and ISO 17025 standards. The technology stack centres on the proprietary Medway suite (Medway Results for clinicians, Medway Practice for consumables and courier ordering, Medway Clinical Trials Portal for pharma/biotech sponsors with HL7 electronic ordering, auditing, blinding, and protocol-specific exclusion flagging) plus the Healius MQLink EDI software that injects results into clinician desktop systems using HL7/PIT data formats. The most recent capability emphasis is on AI-assisted diagnostics, in which machine learning assists pathologists in interpreting results with mandatory human oversight; no automated patient decisions are made by AI. Adjacent digital services include telehealth, eReferrals, online appointment booking, mobile collections, vaccine supply, CPD education and personalised referral pads.

Laverty's revenue model mixes Medicare bulk billing for MBS-eligible pathology tests with out-of-pocket patient payments for non-covered tests (insurance, employment, immigration, legal testing). Commercial streams — including AS/NZS 4308 and AS/NZS 4760 accredited drug and alcohol testing, employee wellness screening, biological monitoring for hazardous exposure, and clinical-trial laboratory services for pharmaceutical and biotech sponsors — generate revenue on a transaction-fee and professional-services basis. The customer base splits between long-tail patient/clinician volume (a referral-driven B2B2C model anchored to 20,000+ doctors) and dedicated enterprise clients (employers and pharma sponsors). Distribution is physical-collection-centre-led with online booking support, while enterprise commercial work is sold through direct field sales.

Short descriptiontext

Laverty Pathology provides medical pathology testing across NSW and ACT via 550+ collection centres, part of Healius Ltd's Australian network. It serves patients, 20,000+ clinicians, employers, and pharmaceutical sponsors with diagnostic, drug-testing, wellness, and clinical-trial laboratory services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersPort Macquarie, Australia
HQ citystring
Port Macquarie
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathology diagnostics services, medical laboratory testing, drug and alcohol screening, clinical trials laboratory, occupational health testing
Industry4 codes
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Diagnostic Pathology Services
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Medicare Pathology Services
TypeSubscription Recurring
Description

Bulk billing for pathology tests covered under Medicare Benefits Schedule (MBS). Revenue received from Medicare Australia for eligible tests requested by healthcare providers.

laverty.com.au
2Out-of-Pocket Patient Payments
TypeTransaction Fee
Description

Patient payments for tests not covered by Medicare, including insurance, employment, visa/immigration, pre-employment, or legal testing. Also for patients not eligible for Medicare or specialized tests not eligible for bulk billing.

laverty.com.au
3Commercial Drug & Alcohol Testing
TypeTransaction Fee
Description

Workplace drug and alcohol testing services for employers including AS4308 urine testing, AS4760 oral fluid testing, hair drug screening, and chain of custody consumables.

laverty.com.au
4Employee Wellness & Occupational Health
TypeTransaction Fee
Description

Corporate wellness screening programs including pre-employment health checks, occupational risk testing, cholesterol, glucose, liver function, thyroid and PSA testing.

laverty.com.au
5Clinical Trial Services
TypeProfessional Services
Description

Comprehensive laboratory services for pharmaceutical, biotech, and research organisations supporting clinical trials (Phases I-IV) including testing, logistics, and data management.

laverty.com.au
6Biological Monitoring Testing
TypeTransaction Fee
Description

Testing services for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and employee health concerns related to chemical exposure.

laverty.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Medicare Bulk Billed Tests
ModelSubscriptionBilling cadencePay-as-you-go
Notes

All pathology tests covered under Medicare Benefits Schedule (MBS) are bulk billed with no patient payment required when requested appropriately by healthcare provider.

laverty.com.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Laverty Pathology operates a network of over 550 collection centres across New South Wales and the Australian Capital Territory, providing medical pathology and diagnostic testing services including blood tests, body fluid testing, tissue pathology, cytology, infectious disease screening, and genetic/molecular testing. The company also delivers commercial services such as NATA-accredited workplace drug and alcohol testing, employee wellness screening, biological monitoring for hazardous chemical exposure, and laboratory services for pharmaceutical and biotech clinical trials. Digital clinician tools (Medway Results, Medway Practice) and Healius MQLink EDI software support electronic ordering and real-time result delivery into clinical software systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Routine pathology tests processed and sent to doctors within 48 hours
+2 more records
Product overview1 text field

Laverty Pathology is a leading pathology provider in New South Wales and Australian Capital Territory, operating as part of the Healius Pathology national network (a top 100 ASX publicly listed entity). The company traces its roots to 1928. It operates as a single integrated pathology services company offering a unified service rather than a modular platform architecture. The core offering encompasses diagnostic pathology testing services delivered through a network of over 550 collection centres, supported by digital platforms including Medway Results (real-time clinician results portal), Medway Practice (consumables and courier management), and Healius MQLink (EDI integration with clinical software systems). Commercial services include accredited drug and alcohol testing (AS/NZS 4308 and AS/NZS 4760), employee wellness screening, biological monitoring testing, and clinical trials laboratory services. The company also provides mobile collections, online appointment booking, eReferrals, telehealth, CPD education, vaccine supply, and personalised referral pads as supplementary service modules.

Product and service8 records
1Pathology Testing Services
CategoryDiagnostic Pathology Services
Description

Comprehensive medical laboratory and pathology testing including blood tests, body fluid testing, tissue pathology, cytology, health screening, infectious disease testing, genetic and molecular testing, hormone testing, and occupational pathology. Bulk-billed under Medicare when requested by a healthcare provider; out-of-pocket fees apply for non-Medicare tests.

2Drug and Alcohol Testing Services
CategoryOccupational Health Services
Description

NATA-accredited workplace drug and alcohol testing for employers, covering urine immunoassay screening (AS/NZS 4308), oral fluid testing (AS/NZS 4760), LCMS confirmation, hair drug screening, breath alcohol testing, chain of custody consumables, policy assistance, and expert consultation.

3Employee Wellness Screening
CategoryOccupational Health Services
Description

Tailored workplace health assessment programs for employers including pre-employment health checks, occupational risk testing (COVID, heavy metals, pesticides, Q fever, hepatitis, TB), cholesterol, glucose, liver function, thyroid, and PSA testing. Available on-site or off-site.

4Biological Monitoring Testing
CategoryOccupational Health Services
Description

Occupational health testing for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and assays for lead, mercury, chromium, zinc, arsenic, cadmium, herbicides, pesticides, Q fever, hepatitis, TB, and cholinesterase levels.

5Clinical Trials Laboratory Services
CategoryClinical Research Services
Description

Comprehensive laboratory services supporting clinical trials (Phases I-IV) for pharmaceutical, biotech, and research organisations. Includes dedicated project management, access to 2,000+ tests, national temperature-controlled logistics, Medway Clinical Trials Portal with HL7 electronic ordering, protocol-specific exclusion flagging, blinding solutions, and integration with Agilex Biolabs partner laboratories.

6Collection Centre Network
CategoryDiagnostic Pathology Services
Description

Network of 550+ collection centres across NSW and ACT, plus 2,000+ nationally via the Healius Pathology network. Most routine tests available without appointment; specialised tests require pre-booking. Includes dedicated corporate collection centres and mobile testing vans.

7Mobile Collections Service
CategoryDiagnostic Pathology Services
Description

Mobile specimen collection for patients unable to attend a collection centre due to medical, mobility, or residential care needs, including home visits and in-facility collections across metro areas with clinical-need prioritisation.

8Healius MQLink Electronic Data Interchange (EDI)
CategoryClinical Software Integration
Description

Proprietary EDI software that automatically downloads Laverty pathology results into clinicians' existing desktop clinical software systems. Supports Windows and macOS and PIT or HL7 data formats. Used and trusted by over 20,000 Australian doctors annually.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Laverty Pathology is part of the Healius Pathology national network, which comprises Australia's premier medical laboratories. The network includes Dorevitch Pathology (Victoria), QML Pathology (Queensland), Abbott Pathology (South Australia), Western Diagnostic Pathology (Western Australia/Northern Territory), TML Pathology (Tasmania), and other specialized pathology services.

Strategic tierCoreTypeTechnology or Integration
Description

Specialized bioanalytical testing partner with FDA-inspected facilities for clinical trial support services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with pharmaceutical, biotech, and research organisations providing Phase I-IV clinical trial laboratory services, testing logistics, and data management.

Strategic tierCoreTypeTechnology or Integration
Description

Integration partnerships with clinical software systems enabling automatic pathology result downloads. Healius MQLink works with all major desktop clinical software systems in Australia.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laverty Pathology

Diagnostic Pathology Serviceslaverty.com.au

Laverty Pathology provides medical pathology testing across NSW and ACT via 550+ collection centres, part of Healius Ltd's Australian network. It serves patients, 20,000+ clinicians, employers, and pharmaceutical sponsors with diagnostic, drug-testing, wellness, and clinical-trial laboratory services.

What Laverty Pathology does

Laverty Pathology is a major provider of pathology and medical diagnostic services in New South Wales and the Australian Capital Territory, operating as a brand under Healius Pathology Pty Ltd — a wholly-owned subsidiary of Healius Ltd, an ASX top-100 listed healthcare group. The business traces its heritage to 1928, when Dr Eva Shipton established one of Australia's first specialist pathology practices in Sydney; over decades it grew by absorbing successive pathology practices (Maynard, Orban, Lindsell, Hale, Cottom, Woods, Moses, Patwardhan) and was reconstituted in 2008 through the merger of SDS Pathology with Symbion Laverty Pathology. Today Laverty runs more than 550 patient collection centres across NSW and ACT, supports more than 20,000 Australian clinicians annually via its Healius MQLink electronic data interchange (EDI) software, and operates as part of a 2,000+-centre national network through Healius.

The company's core product is medical pathology testing — blood, body fluid, tissue, cytology, infectious disease, genetic/molecular, hormone, and occupational health testing — delivered through NATA-accredited laboratories certified to ISO 15189 and ISO 17025 standards. The technology stack centres on the proprietary Medway suite (Medway Results for clinicians, Medway Practice for consumables and courier ordering, Medway Clinical Trials Portal for pharma/biotech sponsors with HL7 electronic ordering, auditing, blinding, and protocol-specific exclusion flagging) plus the Healius MQLink EDI software that injects results into clinician desktop systems using HL7/PIT data formats. The most recent capability emphasis is on AI-assisted diagnostics, in which machine learning assists pathologists in interpreting results with mandatory human oversight; no automated patient decisions are made by AI. Adjacent digital services include telehealth, eReferrals, online appointment booking, mobile collections, vaccine supply, CPD education and personalised referral pads.

Laverty's revenue model mixes Medicare bulk billing for MBS-eligible pathology tests with out-of-pocket patient payments for non-covered tests (insurance, employment, immigration, legal testing). Commercial streams — including AS/NZS 4308 and AS/NZS 4760 accredited drug and alcohol testing, employee wellness screening, biological monitoring for hazardous exposure, and clinical-trial laboratory services for pharmaceutical and biotech sponsors — generate revenue on a transaction-fee and professional-services basis. The customer base splits between long-tail patient/clinician volume (a referral-driven B2B2C model anchored to 20,000+ doctors) and dedicated enterprise clients (employers and pharma sponsors). Distribution is physical-collection-centre-led with online booking support, while enterprise commercial work is sold through direct field sales.

Laverty Pathology firmographics

Firmographics
Name
Laverty Pathology
Legal name
Healius Pathology Pty Ltd
Website
https://laverty.com.au
Company type
Private
Founded year
1928
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Laverty Pathology provides medical pathology testing across NSW and ACT via 550+ collection centres, part of Healius Ltd's Australian network. It serves patients, 20,000+ clinicians, employers, and pharmaceutical sponsors with diagnostic, drug-testing, wellness, and clinical-trial laboratory services.
Ownership category
akta.pro rank

Laverty Pathology industry classification

Industry
Product category
Diagnostic Pathology Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAA
Anatomic Pathology (Histopathology & Cytopathology)
SECONDARYHLACAMAB
Anatomic Pathology LIS & Digital Pathology Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Pathology diagnostics services
  • Medical laboratory testing
  • Drug and alcohol screening
  • Clinical trials laboratory
  • Occupational health testing

Where Laverty Pathology is headquartered

Location

Headquarters

HQ city
Port Macquarie
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Laverty Pathology business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Medicare Pathology Services: Bulk billing for pathology tests covered under Medicare Benefits Schedule (MBS). Revenue received from Medicare Australia for eligible tests requested by healthcare providers.
  2. Out-of-Pocket Patient Payments: Patient payments for tests not covered by Medicare, including insurance, employment, visa/immigration, pre-employment, or legal testing. Also for patients not eligible for Medicare or specialized tests not eligible for bulk billing.
  3. Commercial Drug & Alcohol Testing: Workplace drug and alcohol testing services for employers including AS4308 urine testing, AS4760 oral fluid testing, hair drug screening, and chain of custody consumables.
  4. Employee Wellness & Occupational Health: Corporate wellness screening programs including pre-employment health checks, occupational risk testing, cholesterol, glucose, liver function, thyroid and PSA testing.
  5. Clinical Trial Services: Comprehensive laboratory services for pharmaceutical, biotech, and research organisations supporting clinical trials (Phases I-IV) including testing, logistics, and data management.
  6. Biological Monitoring Testing: Testing services for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and employee health concerns related to chemical exposure.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goMedicare Bulk Billed Tests

Go-to-market motion2 records

Distribution channels5 records

Marketing channels4 records

Laverty Pathology product offering

Product offering

Core offering

Laverty Pathology operates a network of over 550 collection centres across New South Wales and the Australian Capital Territory, providing medical pathology and diagnostic testing services including blood tests, body fluid testing, tissue pathology, cytology, infectious disease screening, and genetic/molecular testing. The company also delivers commercial services such as NATA-accredited workplace drug and alcohol testing, employee wellness screening, biological monitoring for hazardous chemical exposure, and laboratory services for pharmaceutical and biotech clinical trials. Digital clinician tools (Medway Results, Medway Practice) and Healius MQLink EDI software support electronic ordering and real-time result delivery into clinical software systems.

Product overview

Laverty Pathology is a leading pathology provider in New South Wales and Australian Capital Territory, operating as part of the Healius Pathology national network (a top 100 ASX publicly listed entity). The company traces its roots to 1928. It operates as a single integrated pathology services company offering a unified service rather than a modular platform architecture. The core offering encompasses diagnostic pathology testing services delivered through a network of over 550 collection centres, supported by digital platforms including Medway Results (real-time clinician results portal), Medway Practice (consumables and courier management), and Healius MQLink (EDI integration with clinical software systems). Commercial services include accredited drug and alcohol testing (AS/NZS 4308 and AS/NZS 4760), employee wellness screening, biological monitoring testing, and clinical trials laboratory services. The company also provides mobile collections, online appointment booking, eReferrals, telehealth, CPD education, vaccine supply, and personalised referral pads as supplementary service modules.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pathology Testing Services Comprehensive medical laboratory and pathology testing including blood tests, body fluid testing, tissue pathology, cytology, health screening, infectious disease testing, genetic and molecular testing, hormone testing, and occupational pathology. Bulk-billed under Medicare when requested by a healthcare provider; out-of-pocket fees apply for non-Medicare tests.
  • Drug and Alcohol Testing Services NATA-accredited workplace drug and alcohol testing for employers, covering urine immunoassay screening (AS/NZS 4308), oral fluid testing (AS/NZS 4760), LCMS confirmation, hair drug screening, breath alcohol testing, chain of custody consumables, policy assistance, and expert consultation.
  • Employee Wellness Screening Tailored workplace health assessment programs for employers including pre-employment health checks, occupational risk testing (COVID, heavy metals, pesticides, Q fever, hepatitis, TB), cholesterol, glucose, liver function, thyroid, and PSA testing. Available on-site or off-site.
  • Biological Monitoring Testing Occupational health testing for workers exposed to hazardous chemicals including baseline monitoring, ongoing health monitoring, and assays for lead, mercury, chromium, zinc, arsenic, cadmium, herbicides, pesticides, Q fever, hepatitis, TB, and cholinesterase levels.
  • Clinical Trials Laboratory Services Comprehensive laboratory services supporting clinical trials (Phases I-IV) for pharmaceutical, biotech, and research organisations. Includes dedicated project management, access to 2,000+ tests, national temperature-controlled logistics, Medway Clinical Trials Portal with HL7 electronic ordering, protocol-specific exclusion flagging, blinding solutions, and integration with Agilex Biolabs partner laboratories.
  • Collection Centre Network Network of 550+ collection centres across NSW and ACT, plus 2,000+ nationally via the Healius Pathology network. Most routine tests available without appointment; specialised tests require pre-booking. Includes dedicated corporate collection centres and mobile testing vans.
  • Mobile Collections Service Mobile specimen collection for patients unable to attend a collection centre due to medical, mobility, or residential care needs, including home visits and in-facility collections across metro areas with clinical-need prioritisation.
  • Healius MQLink Electronic Data Interchange (EDI) Proprietary EDI software that automatically downloads Laverty pathology results into clinicians' existing desktop clinical software systems. Supports Windows and macOS and PIT or HL7 data formats. Used and trusted by over 20,000 Australian doctors annually.

Quantifiable outcome

  • Routine pathology tests processed and sent to doctors within 48 hours
  • +2 more outcomes

Companies that use Laverty Pathology

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Laverty Pathology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature5 records

Laverty Pathology partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship and core.

  • Healius Pathology NetworkflagshipStrategic or Co-development PartnerLaverty Pathology is part of the Healius Pathology national network, which comprises Australia's premier medical laboratories. The network includes Dorevitch Pathology (Victoria), QML Pathology (Queensland), Abbott Pathology (South Australia), Western Diagnostic Pathology (Western Australia/Northern Territory), TML Pathology (Tasmania), and other specialized pathology services.
  • Agilex BiolabscoreTechnology or IntegrationSpecialized bioanalytical testing partner with FDA-inspected facilities for clinical trial support services.
  • Clinical Trial SponsorscoreStrategic or Co-development PartnerPartnership with pharmaceutical, biotech, and research organisations providing Phase I-IV clinical trial laboratory services, testing logistics, and data management.
  • Healthcare Software VendorscoreTechnology or IntegrationIntegration partnerships with clinical software systems enabling automatic pathology result downloads. Healius MQLink works with all major desktop clinical software systems in Australia.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Laverty Pathology competitors and assessment

Company assessment

Market position

Strengths4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Laverty Pathology compliance and trust

Trust signal

Compliance6 records

Laverty Pathology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laverty Pathology leadership team

Management profile

Number of profiles

Profiles8 records

Laverty Pathology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laverty Pathology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laverty Pathology

What does Laverty Pathology do?

Laverty Pathology operates a network of over 550 collection centres across New South Wales and the Australian Capital Territory, providing medical pathology and diagnostic testing services including blood tests, body fluid testing, tissue pathology, cytology, infectious disease screening, and genetic/molecular testing. The company also delivers commercial services such as NATA-accredited workplace drug and alcohol testing, employee wellness screening, biological monitoring for hazardous chemical exposure, and laboratory services for pharmaceutical and biotech clinical trials. Digital clinician tools (Medway Results, Medway Practice) and Healius MQLink EDI software support electronic ordering and real-time result delivery into clinical software systems.

Is Laverty Pathology a public or private company?

Laverty Pathology is a private company. It is classified as corporate owned and is currently operating.

When was Laverty Pathology founded?

Laverty Pathology was founded in 1928. It employs 501 to 1,000 people.

Where is Laverty Pathology based?

Laverty Pathology is headquartered in Port Macquarie, Australia, in the Oceania region.

How does Laverty Pathology make money?

Six revenue lines are on record. Medicare Pathology Services are the primary driver. The others are out-of-Pocket Patient Payments, commercial Drug & Alcohol Testing, employee Wellness & Occupational Health, clinical Trial Services and biological Monitoring Testing.

Does Laverty Pathology have an API?

No public API is recorded for Laverty Pathology.

What industry is Laverty Pathology in?

Laverty Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology), with a secondary code of HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales